Free provider profile
KALAPPURACKAL JOSEPH, MD
NPI 1922195999
Individual
Psychiatry & Neurology, Psychiatry
Active registration
Save to rep workspaceNPI registry Registry record
Source: CMS NPPES registry, updated continuously. This record was last updated 2016-04-19.
2525 CROOKS RD STE 100, TROY, MI, 48084
248-740-9360
Single practice location
Enumerated 2006-10-09
- — Registration is active in NPPES.
- — Individual clinician record — reachable, but usually not the buyer.
- — Practice phone number is published.
- — Full street address on file for route planning.
- — 1 payer identifiers on file — enrolled with payers.
- — Record last updated 10 years ago.
Medicare Part D prescribing
Source: CMS Medicare Part D Prescribers by Provider, most recent public year.
Part D claims
7,918
Medicare patients
627
Part D drug cost
$882,074
Brand-name share
6.4%
of this prescriber's Part D claims
| Drug | Claims | Medicare cost |
|---|---|---|
| Vraylar (Cariprazine Hcl) | 131 | $234,004 |
| Caplyta (Lumateperone Tosylate) | 50 | $85,172 |
| Rexulti (Brexpiprazole) | 40 | $56,599 |
| Spravato (Esketamine Hcl) | 19 | $42,167 |
| Invega Sustenna (Paliperidone Palmitate) | 14 | $32,554 |
| Lybalvi (Olanzapine/Samidorphan Malate) | 18 | $26,567 |
| Trintellix (Vortioxetine Hydrobromide) | 46 | $24,584 |
| Vilazodone Hcl (Vilazodone Hcl) | 91 | $13,994 |
Want their full drug mix and peer benchmark? Run the free Part D prescriber lookup.
Spravato (esketamine) Medicare billing
Source: CMS Medicare Part B fee-for-service, HCPCS G2082/G2083.
2024319 sessions · 11 patients · $298,348
Full Spravato label-compliance detail — sessions per patient against the FDA label, risk flags and year-over-year trend.
- Registry data comes straight from CMS NPPES, which lists registration, not activity — a listed practice may have moved or closed.
- Part D covers Medicare prescription drug enrollees only. Commercial, Medicaid and cash-pay prescribing is not included, so these figures are a floor on real volume, not the whole picture.
- CMS publishes the Part D file annually, roughly two years behind the prescribing year. Drugs with 10 or fewer claims are suppressed.